Financial Reports

As on December 31, 2025
bt_bb_section_bottom_section_coverage_image

Financial Summary 2025

Revenue
8,685,756 SR

Net Profit
358,851,871 SR

Revenue

Industrial Segment, 9,839,305 SR

Investment Segment, (1,153,549) SR

Profit from the activity

Industrial Segment, (2,533,747) SR

Investment Segment (6,818,926) SR

Discontinuous operations 368,204,544 SR

Assets

71.1%
Current Assets
740,450,020 SR
28.9%
Fixed Assets
300,808,808 SR

Liabilities and Shareholder Equity

8.5%
Liabilities
88,944,791 SR
91.5%
Shareholder Equity
952,314,037 SR

2025 Milestones

Recording a net profit for the year of SAR 358.85 million.
Completion of all legal and financial studies related to the fundamental deal with Dallah Healthcare Company.
Helping subsidiaries' companies list their shares on the financial market.
Approval by the company’s shareholders at the Extraordinary General Assembly meeting held on 28 September 2025 to extinguish the share premium amounting to SAR 59.76 million against accumulated losses.
Amendment of Article Three of the company’s bylaws relating to the company’s objectives, including the investment of the company’s funds in shares and other securities.

Future Plans

The company seeks to reformulate its investment strategy following the completion of the key transaction related to the sale of the subsidiaries, with a focus on diversifying investments, enhancing sustainable growth, and improving financial performance efficiency, in line with shareholders’ aspirations and with the aim of achieving attractive long-term returns.

Future Expectations

During the coming phase, the company is working on further developing its investment direction in light of its new structure after the exclusion of the medical services segment during 2025.
The company is also focusing on studying available investment opportunities and expanding its investments in shares, securities, and other investment assets in a manner that supports sustainable growth and maximizes shareholder value.

Structural changes

Completion of the transaction for the sale of the company’s full stakes in Al-Ahsa Medical Services Company and Al-Salam Medical Services Company during 2025.
Extinguishment of the share premium amounting to SAR 59.76 million against accumulated losses.
Amendment of the company’s objectives in the bylaws to allow the investment of the company’s funds in shares and other securities.
Reduction of non-controlling interests to zero as a result of the disposal of the subsidiaries during 2025.
bt_bb_section_top_section_coverage_image
https://ayyan.com.sa/wp-content/uploads/2020/08/floating_image_06.png
https://ayyan.com.sa/wp-content/uploads/2020/08/floating_image_08.png

For more information

You can download 2025 Board Director Report
bt_bb_section_top_section_coverage_image
bt_bb_section_bottom_section_coverage_image

Other Year Reports

https://ayyan.com.sa/wp-content/uploads/2020/08/floating_image_04.png